Bruker Corporation
Statements
Segments
US companies must disclose in their mandatory reports how revenue breaks down across business segments, regions and product lines. We read that breakdown for you straight from the annual and quarterly reports (10-K and 10-Q) of Bruker Corporation (BRKR). It shows which part of the business is growing — and which one is holding it back.
Revenue by business segment
| Segment | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| BSI CALID | $653.9M 32.7% | $819.6M 33.7% · +25.3% | $822.2M 32.5% · +0.3% | $960.4M 32.4% · +16.8% | $1.09B 32.3% · +13.9% | $1.21B 35.1% · +10.7% |
| BSI NANO | $556.1M 27.8% | $697.5M 28.7% · +25.4% | $787.0M 31.1% · +12.8% | $941.9M 31.8% · +19.7% | $1.10B 32.5% · +16.6% | $1.08B 31.5% · -1.3% |
| BSI BioSpin | $600.0M 30.0% | $691.0M 28.4% · +15.2% | $696.7M 27.5% · +0.8% | $798.5M 26.9% · +14.6% | $905.7M 26.8% · +13.4% | $878.8M 25.5% · -3.0% |
| BEST | $189.5M 9.5% | $223.8M 9.2% · +18.1% | $224.8M 8.9% · +0.4% | $263.7M 8.9% · +17.3% | $283.0M 8.4% · +7.3% | $270.9M 7.9% · -4.3% |
| Unallocated Expenses | – | – | – | – | – | – |
Large figure: segment revenue. Below it the share of revenue in that period and the change against the prior year.
| Segment | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| BSI CALID | $152.2M 23.3% | $227.2M 27.7% | $216.4M 26.3% | – | $246.2M 22.5% | – |
| BSI NANO | $23.6M 4.2% | $73.4M 10.5% | – | $158.4M 16.8% | $123.9M 11.3% | $101.1M 9.3% |
| BSI BioSpin | $121.6M 20.3% | $158.2M 22.9% | – | – | – | – |
| BEST | $6.2M 3.3% | $22.2M 9.9% | – | – | $35.1M 12.4% | $26.7M 9.9% |
| Unallocated Expenses | – | – | $72.9M | $109.4M | $264.9M | $364.8M |
Large figure: segment operating income. Below it the margin, that is operating income measured against the revenue of the same segment.
Revenue by region
| Segment | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Europe Excluding Germany | – | – | – | $699.7M 23.6% | $873.0M 25.9% · +24.8% | $950.2M 27.7% · +8.8% |
| United States | $455.9M 22.9% | $601.0M 24.9% · +31.8% | $696.1M 27.5% · +15.8% | $777.7M 26.2% · +11.7% | $938.5M 27.9% · +20.7% | $891.3M 25.9% · -5.0% |
| Asia Pacific Excluding China | – | – | – | $460.9M 15.5% | $518.5M 15.4% · +12.5% | $552.6M 16.1% · +6.6% |
| China | $313.5M 15.8% | $357.6M 14.8% · +14.1% | $396.5M 15.7% · +10.9% | $528.1M 17.8% · +33.2% | $471.2M 14.0% · -10.8% | $475.8M 13.8% · +1.0% |
| Germany | $244.9M 12.3% | $262.6M 10.9% · +7.2% | $247.4M 9.8% · -5.8% | $281.5M 9.5% · +13.8% | $310.7M 9.2% · +10.4% | $297.0M 8.6% · -4.4% |
| Other | $137.8M 6.9% | $167.1M 6.9% · +21.3% | $190.4M 7.5% · +13.9% | $216.6M 7.3% · +13.8% | $254.5M 7.6% · +17.5% | $269.6M 7.8% · +5.9% |
| Rest of Europe | $519.8M 26.2% | $658.1M 27.2% · +26.6% | $591.9M 23.4% · -10.1% | – | – | – |
| Asia Pacific | $315.6M 15.9% | $371.5M 15.4% · +17.7% | – | – | – | – |
| Rest of Asia Pacific | – | – | $408.4M 16.1% | – | – | – |
Large figure: segment revenue. Below it the share of revenue in that period and the change against the prior year.
Revenue by product line
| Segment | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Product | $1.64B 82.4% | $2.02B 83.4% · +23.1% | $2.11B 83.4% · +4.6% | $2.46B 82.9% · +16.5% | $2.76B 82.0% · +12.3% | $2.77B 80.5% · +0.3% |
| Other | $6.0M 0.3% | $7.4M 0.3% · +23.3% | $420.8M 16.6% · +5,586.5% | $506.9M 17.1% · +20.5% | $607.2M 18.0% · +19.8% | $670.1M 19.5% · +10.4% |
| Service | $343.4M 17.3% | $393.2M 16.3% · +14.5% | – | – | – | – |
Large figure: segment revenue. Below it the share of revenue in that period and the change against the prior year.
Segment and region names are the ones the company itself uses and are shown as reported. Change and share refer to revenue.
Data as of: August 11, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Segment figures: SEC EDGAR (10-K/10-Q reports)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.